IL33 and tuberculosis: IL-33 secretion in the group of patients with HIV/TB coinfection who were naïve to anti-tuberculosis and antiretroviral therapy was increased by 2.6 times, and 2.4 times compared to the group of patients with HIV alone (33.1 ± 30.9 pg/ml vs 12.6 ± 8.7 pg/ml, p=0.002) and controls (33.1 ± 30.9 pg/ml vs 14.0 ± 3.4 pg/ml, p<0.0001) respectively (Figure 2, A).